Man with No Memory | The Accident  | S55-E1

Man with No Memory | The Accident | S55-E1

Up next

The Mystery of Stuxnet | Cracking the Code | S57-E1

In the summer of 2010, a mysterious computer virus called Stuxnet lands on the desk of Symantec cybersecurity analyst Liam O’Murchu. Stuxnet is unlike anything O’Murchu has ever seen: a highly sophisticated piece of malware that serves no obvious purpose. O’Murchu and his coll ...

  Show more

The Mystery of Stuxnet | Cracking the Code | S57-E1

In the summer of 2010, a mysterious computer virus called Stuxnet lands on the desk of Symantec cybersecurity analyst Liam O’Murchu. Stuxnet is unlike anything O’Murchu has ever seen: a highly sophisticated piece of malware that serves no obvious purpose. O’Murchu and his colleag ...  Show more

Recommended Episodes

Your Next Pain Prescription Could Come without Addiction Risk
Science Quickly

The Food and Drug Administration has granted priority review to suzetrigine, a novel painkiller. It’s part of a new class of medications that could provide relief to those with chronic pain. The drugs target sodium channels on nerve cells, stopping pain signaling at the periphery ...  Show more

Cracking the Code on Pain Relief
I AM BIO

Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment ...  Show more

Big Pharma, Big Problems
Looking Within

A deep dive into the beginnings of the opioid epidemic, this episodes serves to expose Purdue Pharma’s deceitful claims, which allowed prescriptions of Oxycontin to go out of control. With a look at the ramifications on ethical, legal, and socio-economical levels, this episode re ...  Show more

Stalling for Survival - A Lonely Fight Against a Deadly Medicine
Cautionary Tales with Tim Harford

In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with France ...  Show more